UK Markets closed

J&J CFO on Earnings, Immunology Portfolio and Pricing Pressure

Jan.22 -- Joseph Wolk, Johnson & Johnson chief financial officer, discusses the company's fourth-quarter results, drug portfolio plans and industry pricing pressure with Bloomberg's David Westin on "Balance of Power."